422 related articles for article (PubMed ID: 23159294)
1. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
3. Biomarker Identification through Proteomics in Colorectal Cancer.
Martín-García D; García-Aranda M; Redondo M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396959
[TBL] [Abstract][Full Text] [Related]
4. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
Ang CS; Baker MS; Nice EC
Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
[TBL] [Abstract][Full Text] [Related]
6. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
[TBL] [Abstract][Full Text] [Related]
7. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
Corbo C; Cevenini A; Salvatore F
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
[TBL] [Abstract][Full Text] [Related]
9. Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening.
Tang M; Zeng L; Zeng Z; Liu J; Yuan J; Wu D; Lu Y; Zi J; Ye M
J Proteomics; 2021 Jul; 243():104246. PubMed ID: 33915303
[TBL] [Abstract][Full Text] [Related]
10. Proteomics for early detection of colorectal cancer: recent updates.
Alnabulsi A; Murray GI
Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
12. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
Cevenini A; Orrù S; Imperlini E
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
[TBL] [Abstract][Full Text] [Related]
13. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
14. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
15. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
[TBL] [Abstract][Full Text] [Related]
16. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
[TBL] [Abstract][Full Text] [Related]
17. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomic biomarkers in colorectal cancers: clinical applications.
Binetti M; Lauro A; Vaccari S; Cervellera M; Tonini V
Expert Rev Proteomics; 2020 May; 17(5):355-363. PubMed ID: 32536221
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]